{"id":"https://openalex.org/W2943663735","doi":"https://doi.org/10.1038/s41419-019-1593-2","title":"Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia","display_name":"Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia","publication_year":2019,"publication_date":"2019-05-01","ids":{"openalex":"https://openalex.org/W2943663735","doi":"https://doi.org/10.1038/s41419-019-1593-2","mag":"2943663735","pmid":"https://pubmed.ncbi.nlm.nih.gov/31043590","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6494825"},"language":"en","primary_location":{"id":"doi:10.1038/s41419-019-1593-2","doi":"https://doi.org/10.1038/s41419-019-1593-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41419-019-1593-2","pdf_url":"https://www.nature.com/articles/s41419-019-1593-2.pdf","source":{"id":"https://openalex.org/S185208586","display_name":"Cell Death and Disease","issn_l":"2041-4889","issn":["2041-4889"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Death & Disease","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41419-019-1593-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079371774","display_name":"Sofiane Berrazouane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405256986","display_name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/04rgqcd02","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256986","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405257837","display_name":"CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/05qn5kv73","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sofiane Berrazouane","raw_affiliation_strings":["Division of Immune and Infectious Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Quebec city, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Immune and Infectious Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Quebec city, Canada","institution_ids":["https://openalex.org/I4405256986","https://openalex.org/I4405257837"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marc Boisvert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405256986","display_name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/04rgqcd02","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256986","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405257837","display_name":"CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/05qn5kv73","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marc Boisvert","raw_affiliation_strings":["Division of Immune and Infectious Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Quebec city, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Immune and Infectious Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Quebec city, Canada","institution_ids":["https://openalex.org/I4405256986","https://openalex.org/I4405257837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086255034","display_name":"Suzanne Salti","orcid":"https://orcid.org/0000-0003-4792-668X","observed_orcids":["https://orcid.org/0000-0003-4792-668X"]},"institutions":[{"id":"https://openalex.org/I4210142730","display_name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0410a8y51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Suzanne Salti","raw_affiliation_strings":["CHUM Research Center and Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHUM Research Center and Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada","institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072045277","display_name":"Walid M. Mourad","orcid":"https://orcid.org/0000-0002-1859-9387","observed_orcids":["https://orcid.org/0000-0002-1859-9387"]},"institutions":[{"id":"https://openalex.org/I4210142730","display_name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0410a8y51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Walid Mourad","raw_affiliation_strings":["CHUM Research Center and Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHUM Research Center and Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, Canada","institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017519158","display_name":"Reem Al\u2010Daccak","orcid":"https://orcid.org/0000-0002-6146-2845","observed_orcids":["https://orcid.org/0000-0002-6146-2845"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Reem Al-Daccak","raw_affiliation_strings":["H\u00f4pital St-Louis, INSERM Unit 976, Universit\u00e9 Paris-Diderot, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f4pital St-Louis, INSERM Unit 976, Universit\u00e9 Paris-Diderot, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210144610","https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056795230","display_name":"Fr\u00e9d\u00e9ric Barab\u00e9","orcid":"https://orcid.org/0000-0003-0024-3611","observed_orcids":["https://orcid.org/0000-0003-0024-3611"]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]},{"id":"https://openalex.org/I4405256986","display_name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/04rgqcd02","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256986","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405257837","display_name":"CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/05qn5kv73","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Fr\u00e9d\u00e9ric Barab\u00e9","raw_affiliation_strings":["Department of Medicine, Faculty of Medicine, Universit\u00e9 Laval, Quebec city, Canada","Division of Immune and Infectious Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Quebec city, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Faculty of Medicine, Universit\u00e9 Laval, Quebec city, Canada","institution_ids":["https://openalex.org/I43406934"]},{"raw_affiliation_string":"Division of Immune and Infectious Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Quebec city, Canada","institution_ids":["https://openalex.org/I4405256986","https://openalex.org/I4405257837"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085251031","display_name":"Fawzi Aoudjit","orcid":"https://orcid.org/0000-0001-9579-2941","observed_orcids":["https://orcid.org/0000-0001-9579-2941"]},"institutions":[{"id":"https://openalex.org/I4210093650","display_name":"Centre hospitalier universitaire de Qu\u00e9bec","ror":"https://ror.org/006a7pj43","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210093650","https://openalex.org/I4210139015","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]},{"id":"https://openalex.org/I4405256986","display_name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/04rgqcd02","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256986","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405257837","display_name":"CHU de Qu\u00e9bec-Universit\u00e9 Laval","ror":"https://ror.org/05qn5kv73","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Fawzi Aoudjit","raw_affiliation_strings":["Department of Microbiology-infectious Diseases and Immunology, Faculty of Medicine, Universit\u00e9 Laval, Quebec city, Canada. fawzi.aoudjit@crchudequebec.ulaval.ca","Division of Immune and Infectious Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Quebec city, Canada. fawzi.aoudjit@crchudequebec.ulaval.ca","Department of Microbiology-infectious Diseases and Immunology, Faculty of Medicine, Universit\u00e9 Laval, Quebec city, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology-infectious Diseases and Immunology, Faculty of Medicine, Universit\u00e9 Laval, Quebec city, Canada. fawzi.aoudjit@crchudequebec.ulaval.ca","institution_ids":["https://openalex.org/I43406934"]},{"raw_affiliation_string":"Division of Immune and Infectious Diseases, CHU de Qu\u00e9bec-Universit\u00e9 Laval Research Center, Quebec city, Canada. fawzi.aoudjit@crchudequebec.ulaval.ca","institution_ids":["https://openalex.org/I4210093650","https://openalex.org/I4405256986","https://openalex.org/I4405257837"]},{"raw_affiliation_string":"Department of Microbiology-infectious Diseases and Immunology, Faculty of Medicine, Universit\u00e9 Laval, Quebec city, Canada","institution_ids":["https://openalex.org/I43406934"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5085251031"],"corresponding_institution_ids":["https://openalex.org/I4210093650","https://openalex.org/I43406934","https://openalex.org/I4405256986","https://openalex.org/I4405257837"],"apc_list":{"value":3760,"currency":"USD","value_usd":3760},"apc_paid":{"value":3760,"currency":"USD","value_usd":3760},"fwci":3.1176,"has_fulltext":true,"cited_by_count":42,"citation_normalized_percentile":{"value":0.90884829,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"10","issue":"5","first_page":"357","last_page":"357"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.07639999687671661,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta1-integrin","display_name":"beta1 integrin","score":0.9629999995231628},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.9350000023841858},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8040000200271606},{"id":"https://openalex.org/keywords/matrigel","display_name":"Matrigel","score":0.8460000157356262},{"id":"https://openalex.org/keywords/type-i-collagen","display_name":"type I collagen","score":0.8690000176429749},{"id":"https://openalex.org/keywords/extracellular-matrix-adhesion","display_name":"extracellular matrix adhesion","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pyk2","display_name":"Pyk2","score":0.9779999852180481},{"id":"https://openalex.org/keywords/integrin-blockade","display_name":"integrin blockade","score":0.5690000057220459},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6060000061988831},{"id":"https://openalex.org/keywords/drug-transporters","display_name":"drug transporters","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.7406355142593384},{"id":"https://openalex.org/C2778608917","wikidata":"https://www.wikidata.org/wiki/Q6787805","display_name":"Matrigel","level":3,"score":0.7116745710372925},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6381348371505737},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6103516221046448},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.5148069262504578},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4559018313884735},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4363562762737274},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3779231011867523},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3452947735786438},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.30308037996292114},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16289150714874268},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10932087898254395},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.09840261936187744},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002448","descriptor_name":"Cell Adhesion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003094","descriptor_name":"Collagen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003094","descriptor_name":"Collagen","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005109","descriptor_name":"Extracellular Matrix","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005109","descriptor_name":"Extracellular Matrix","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007797","descriptor_name":"Laminin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007797","descriptor_name":"Laminin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011509","descriptor_name":"Proteoglycans","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011509","descriptor_name":"Proteoglycans","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015973","descriptor_name":"Gene Expression Regulation, Leukemic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019012","descriptor_name":"Integrin beta1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019012","descriptor_name":"Integrin beta1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019169","descriptor_name":"Jurkat Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024042","descriptor_name":"Collagen Type I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D024042","descriptor_name":"Collagen Type I","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051418","descriptor_name":"Focal Adhesion Kinase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051418","descriptor_name":"Focal Adhesion Kinase 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051418","descriptor_name":"Focal Adhesion Kinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054218","descriptor_name":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D054218","descriptor_name":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D054218","descriptor_name":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D054218","descriptor_name":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D061251","descriptor_name":"Primary Cell Culture","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1038/s41419-019-1593-2","doi":"https://doi.org/10.1038/s41419-019-1593-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41419-019-1593-2","pdf_url":"https://www.nature.com/articles/s41419-019-1593-2.pdf","source":{"id":"https://openalex.org/S185208586","display_name":"Cell Death and Disease","issn_l":"2041-4889","issn":["2041-4889"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Death & Disease","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5478531","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6494825","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:31043590","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31043590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell death & disease","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6494825","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6494825/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Death Dis","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:86df1cdee8054481b599234a92f72797","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/86df1cdee8054481b599234a92f72797","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cell Death and Disease, Vol 10, Iss 5, Pp 1-13 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41419-019-1593-2","doi":"https://doi.org/10.1038/s41419-019-1593-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41419-019-1593-2","pdf_url":"https://www.nature.com/articles/s41419-019-1593-2.pdf","source":{"id":"https://openalex.org/S185208586","display_name":"Cell Death and Disease","issn_l":"2041-4889","issn":["2041-4889"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Death & Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5140329699","display_name":null,"funder_award_id":"MOP-136819","funder_id":"https://openalex.org/F4320319880","funder_display_name":"Government of Canada"},{"id":"https://openalex.org/G6287070764","display_name":"Elucidating the role of alpha2beta1 integrin in the chemoresistance of acute lymphoblastic leukemia.","funder_award_id":"136819_1","funder_id":"https://openalex.org/F4320334506","funder_display_name":"Canadian Institutes of Health Research"}],"funders":[{"id":"https://openalex.org/F4320310137","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03"},{"id":"https://openalex.org/F4320319880","display_name":"Government of Canada","ror":"https://ror.org/010q4q527"},{"id":"https://openalex.org/F4320334506","display_name":"Canadian Institutes of Health Research","ror":"https://ror.org/01gavpb45"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2943663735.pdf","grobid_xml":"https://content.openalex.org/works/W2943663735.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W1262816711","https://openalex.org/W1528751727","https://openalex.org/W1564077374","https://openalex.org/W1576745000","https://openalex.org/W1599319991","https://openalex.org/W1601638672","https://openalex.org/W1913709492","https://openalex.org/W1928865219","https://openalex.org/W1964222612","https://openalex.org/W1965570423","https://openalex.org/W1968324001","https://openalex.org/W1983164100","https://openalex.org/W1988638083","https://openalex.org/W1988645163","https://openalex.org/W1990518937","https://openalex.org/W2009270584","https://openalex.org/W2017589730","https://openalex.org/W2019136692","https://openalex.org/W2021314764","https://openalex.org/W2029510364","https://openalex.org/W2029583475","https://openalex.org/W2034278840","https://openalex.org/W2035197415","https://openalex.org/W2053737668","https://openalex.org/W2056031607","https://openalex.org/W2066738380","https://openalex.org/W2070962119","https://openalex.org/W2091972503","https://openalex.org/W2100098810","https://openalex.org/W2100769394","https://openalex.org/W2107342944","https://openalex.org/W2123416522","https://openalex.org/W2125445451","https://openalex.org/W2129741180","https://openalex.org/W2135347682","https://openalex.org/W2149787043","https://openalex.org/W2154768755","https://openalex.org/W2157007010","https://openalex.org/W2163964890","https://openalex.org/W2165445740","https://openalex.org/W2180166599","https://openalex.org/W2326572877","https://openalex.org/W2333361482","https://openalex.org/W2468077777","https://openalex.org/W2518298055","https://openalex.org/W2534765849","https://openalex.org/W2749830411","https://openalex.org/W2788136493","https://openalex.org/W2796552195","https://openalex.org/W2888052304","https://openalex.org/W2896103954"],"related_works":["https://openalex.org/W2017589730","https://openalex.org/W7028366621","https://openalex.org/W2995317502","https://openalex.org/W3180649351","https://openalex.org/W2135347682","https://openalex.org/W2885799426","https://openalex.org/W2748457089","https://openalex.org/W2606181681","https://openalex.org/W3002978601","https://openalex.org/W6907838846"],"abstract_inverted_index":{"Growing":[0],"evidence":[1],"indicates":[2],"that":[3,58,142,184],"cell":[4,63],"adhesion":[5,22],"to":[6,81,101,194],"extracellular":[7],"matrix":[8],"(ECM)":[9],"plays":[10],"an":[11],"important":[12],"role":[13,37,175],"in":[14,41,107,113,179,199],"cancer":[15],"chemoresistance.":[16],"Leukemic":[17],"T":[18],"cells":[19,100],"express":[20],"several":[21],"receptors":[23],"of":[24,38,43,60,88,116,133,168,176],"the":[25,36,104,108,114,131,134,152,166,174,185],"\u03b21":[26,39,84,89,177,186],"integrin":[27,90,121,178,187],"subfamily":[28],"with":[29,33,68,91],"which":[30],"they":[31],"interact":[32],"ECM.":[34],"However,":[35],"integrins":[40],"chemoresistance":[42,125,149,181,196],"T-cell":[44],"acute":[45],"lymphoblastic":[46],"leukemia":[47],"(T-ALL)":[48],"is":[49],"still":[50],"ill":[51],"defined.":[52],"In":[53],"this":[54],"study,":[55],"we":[56],"demonstrate":[57],"interactions":[59],"human":[61,200],"T-ALL":[62,124,180],"lines":[64],"and":[65,73,111,148,163,182,197],"primary":[66],"blasts":[67],"three-dimensional":[69],"matrices":[70],"including":[71],"Matrigel":[72],"collagen":[74],"type":[75],"I":[76],"gel":[77],"promote":[78],"their":[79],"resistance":[80],"doxorubicin":[82,128,146],"via":[83],"integrin.":[85],"The":[86],"blockade":[87],"a":[92,191],"specific":[93],"neutralizing":[94],"antibody":[95],"sensitized":[96],"xenografted":[97],"CEM":[98],"leukemic":[99,105],"doxorubicin,":[102],"diminished":[103,165],"burden":[106],"bone":[109],"marrow":[110],"resulted":[112],"extension":[115],"animal":[117],"survival.":[118],"Mechanistically,":[119],"Matrigel/\u03b21":[120,143],"interaction":[122,144],"enhanced":[123,145],"by":[126,150],"promoting":[127],"efflux":[129,147],"through":[130],"activation":[132],"ABCC1":[135],"drug":[136],"transporter.":[137],"Finally,":[138],"our":[139],"findings":[140],"showed":[141],"activating":[151],"FAK-related":[153],"proline-rich":[154],"tyrosine":[155],"kinase":[156],"2":[157],"(PYK2)":[158],"as":[159],"both":[160],"PYK2":[161],"inhibitor":[162],"siRNA":[164],"effect":[167],"Matrigel.":[169],"Collectively,":[170],"these":[171],"results":[172],"support":[173],"suggest":[183],"pathway":[188],"can":[189],"constitute":[190],"therapeutic":[192],"target":[193],"avoid":[195],"relapsed-disease":[198],"T-ALL.":[201]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-05-09T00:00:00"}